PATHOLOGY RESEARCH AND PRACTICE

Scope & Guideline

Transforming Understanding Through Peer-Reviewed Excellence

Introduction

Immerse yourself in the scholarly insights of PATHOLOGY RESEARCH AND PRACTICE with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0344-0338
PublisherELSEVIER GMBH
Support Open AccessNo
CountryGermany
TypeJournal
Convergefrom 1978 to 2024
AbbreviationPATHOL RES PRACT / Pathol. Res. Pract.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressHACKERBRUCKE 6, 80335 MUNICH, GERMANY

Aims and Scopes

The journal 'Pathology Research and Practice' focuses on advancing the understanding of pathological processes and their implications for various diseases through rigorous research and clinical studies. It aims to publish high-quality research that contributes to the field of pathology, with a particular emphasis on molecular mechanisms, diagnostic advancements, and therapeutic implications.
  1. Molecular Pathology:
    Research exploring the molecular mechanisms underlying diseases, including cancer genomics, epigenetics, and the role of non-coding RNAs in tumor progression.
  2. Histopathological Studies:
    Detailed examinations of tissue specimens to identify disease patterns, tumor characteristics, and their correlation with clinical outcomes.
  3. Diagnostic Innovations:
    Development and validation of novel biomarkers and diagnostic techniques, including immunohistochemical markers and next-generation sequencing applications.
  4. Cancer Immunology:
    Studies focused on the tumor microenvironment, immune evasion mechanisms, and the role of immune checkpoints in cancer progression and therapy.
  5. Therapeutic Research:
    Research on therapeutic targets, including drug resistance mechanisms, and the potential of novel treatment modalities such as immunotherapy and gene therapy.
The journal has recently seen a surge in interest in several emerging themes, reflecting the evolving landscape of pathology research. These trends indicate a shift towards more complex and integrative approaches to understanding diseases.
  1. Role of Non-coding RNAs:
    Increasing research on non-coding RNAs, particularly their roles in cancer progression, chemoresistance, and as potential therapeutic targets, showcases the expanding understanding of RNA biology in pathology.
  2. Tumor Microenvironment Studies:
    A growing emphasis on the tumor microenvironment, including interactions between cancer cells and stromal components, is evident, highlighting its significance in cancer biology and treatment responses.
  3. Artificial Intelligence and Digital Pathology:
    The integration of artificial intelligence and machine learning techniques in pathology for diagnostic purposes is a rapidly emerging theme, showcasing the potential for enhanced accuracy and efficiency in diagnostics.
  4. Immunotherapy and Cancer Treatment:
    Research focusing on immunotherapeutic strategies, including the exploration of immune checkpoint inhibitors and their roles in various cancers, is gaining momentum, reflecting a significant shift in cancer treatment paradigms.
  5. Personalized Medicine Approaches:
    Emerging studies on personalized medicine in pathology, particularly the use of genetic and epigenetic profiling to tailor treatments, are becoming increasingly prevalent.

Declining or Waning

While the journal continues to explore a diverse range of topics, certain areas of focus have seen a decline in prominence over recent years. These waning scopes may reflect shifts in research trends or emerging priorities within the field of pathology.
  1. Traditional Histopathology Techniques:
    There has been a noticeable decrease in studies emphasizing traditional histopathological techniques without molecular or genetic components, as the field moves towards more integrative approaches that combine histology with molecular data.
  2. Single Disease Focus:
    Research centered exclusively on individual diseases without consideration of broader implications or multi-disease comparisons is becoming less common, as interdisciplinary studies gain traction.
  3. Basic Pathophysiology Studies:
    Papers focusing solely on basic pathophysiological mechanisms without direct clinical or therapeutic relevance are less frequently published, indicating a trend towards translational research.

Similar Journals

APMIS

Unveiling Groundbreaking Insights in Immunology and Microbiology
Publisher: WILEYISSN: 0903-4641Frequency: 12 issues/year

APMIS is a distinguished academic journal published by WILEY that serves as a vital resource for researchers and practitioners in the fields of Immunology, Allergy, Microbiology, and Pathology. Established in 1988 and continuing its mission through 2024, this journal facilitates the dissemination of high-quality research findings, contributing to the intersection of multiple disciplines within the medical sciences. With an ISSN of 0903-4641 and an E-ISSN of 1600-0463, APMIS is categorized in 2023's Q2 and Q3 quartiles across various domains, reflecting its significant impact, with rankings such as #50/208 in Pathology and Forensic Medicine and #121/233 in Immunology and Allergy. Although it currently does not offer open access options, the journal’s rigorous peer-review process ensures that published articles maintain the highest standards of scholarship. With its focus on innovative research, APMIS continues to occupy a pivotal role for those seeking to advance their expertise and contribute to scientific dialogue in these essential fields.

JOURNAL OF GENE MEDICINE

Pioneering Research in Genetics and Drug Discovery
Publisher: WILEYISSN: 1099-498XFrequency: 12 issues/year

The Journal of Gene Medicine, published by Wiley, stands as a pivotal resource in the field of gene therapy and molecular medicine, with a rich history of dissemination of impactful research since its inception in 1998. With an ISSN of 1099-498X and an E-ISSN of 1521-2254, this esteemed journal plays a crucial role in advancing our understanding of genetics and drug discovery, reflected in its impressive 2023 Scopus rankings where it holds a Q2 classification in Drug Discovery and Q3 in several genetics-related categories. The journal aims to facilitate the exchange of high-quality research findings that bridge the gap between laboratory and clinical applications, making it an essential platform for researchers, academics, and healthcare professionals committed to the forefront of genetic innovation. Although it does not currently offer open access options, its reputation for rigorous peer review ensures that all published work meets the highest academic standards, providing a reliable reference for scientific inquiry in the United States and beyond. As the field rapidly evolves, the Journal of Gene Medicine remains at the helm, guiding future discoveries with its influential publications and comprehensive insights.

EXPERIMENTAL AND MOLECULAR PATHOLOGY

Unraveling molecular mysteries in pathology.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0014-4800Frequency: 6 issues/year

EXPERIMENTAL AND MOLECULAR PATHOLOGY, a distinguished journal published by Academic Press Inc Elsevier Science, is recognized for its significant contributions to the fields of pathology, clinical biochemistry, and molecular biology. With an ISSN of 0014-4800 and an E-ISSN of 1096-0945, this journal provides a platform for the dissemination of high-quality research articles, reviews, and experimental studies that deepen our understanding of disease mechanisms and diagnostic pathways. Since its inception in 1962 and through its converged publication years, the journal has consistently maintained a solid impact in the academic community, achieving high Scopus rankings—ranked #15 in the field of Pathology and Forensic Medicine and #22 in Clinical Biochemistry, showcasing a commendable percentile standing of 93rd and 81st respectively in 2023. The journal is accessible through various academic libraries and institutional subscriptions, making it an essential resource for researchers, professionals, and students committed to advancing knowledge in these critical areas. With a categorization that includes Q1 rankings in Pathology and Forensic Medicine, EXPERIMENTAL AND MOLECULAR PATHOLOGY stands as a prominent venue for pioneering scientific inquiry and collaborative advancement in molecular diagnostics and therapeutic strategies.

Annals of Diagnostic Pathology

Transforming Medical Science with Diagnostic Innovations.
Publisher: ELSEVIER SCIENCE INCISSN: 1092-9134Frequency: 6 issues/year

Annals of Diagnostic Pathology, published by Elsevier Science Inc, is a pivotal journal in the field of diagnostic pathology that has significantly contributed to the advancement of medical science since its inception in 1997. With an ISSN of 1092-9134 and E-ISSN of 1532-8198, this esteemed journal is positioned within the Q2 category in both Medicine (miscellaneous) and Pathology and Forensic Medicine, reflecting its high-quality research contributions, showcased by its ranking at #73 out of 208 in Scopus for the latter category. The journal's scope encompasses various aspects of diagnostic pathology, from innovative techniques to critical reviews of pathologic findings, making it an essential resource for researchers, medical professionals, and students dedicated to enhancing diagnostic accuracy and patient care. Although it does not currently offer open access options, its wide readership and impactful publications continue to influence clinical practices and research agendas. With a convergence period extending to 2024, Annals of Diagnostic Pathology remains a leading platform for disseminating valuable knowledge in this dynamic field.

Annual Review of Pathology-Mechanisms of Disease

Pioneering Research in the Mechanisms of Disease
Publisher: ANNUAL REVIEWSISSN: 1553-4006Frequency: 1 issue/year

Annual Review of Pathology: Mechanisms of Disease is a premier scholarly journal published by ANNUAL REVIEWS that systematically reviews significant advancements in the field of pathology and the mechanisms underpinning various diseases. With an ISSN of 1553-4006 and an E-ISSN of 1553-4014, the journal has established its importance within the academic community, evidenced by its prestigious Q1 rankings in several categories including medicine, pathology, forensic medicine, and plant science for 2023. Notably, it ranks #1 out of 208 in the pathology and forensic medicine category, placing it in the 99th percentile according to Scopus metrics. Although not an open-access journal, it offers crucial insights to researchers, professionals, and students alike by providing a comprehensive understanding of pathophysiological concepts and emerging trends. The journal continues to be an essential resource for those dedicated to advancing research and practical applications in disease mechanisms.

AJSP-Reviews and Reports

Elevating Pathology Research Through Peer Review
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2381-5949Frequency: 6 issues/year

AJSP-Reviews and Reports is a peer-reviewed journal dedicated to the advancement of knowledge within the field of pathology and forensic medicine. Published by the renowned Lippincott Williams & Wilkins, this journal plays a vital role in disseminating insightful reviews and reports that contribute to the understanding and application of diagnostic practices and forensic investigations. While currently listed in the fourth quartile (Q4) within its category according to the 2023 metrics, the journal is committed to enhancing its impact and fostering scholarly dialogue among researchers, professionals, and students in the medical community. Despite challenges in Scopus rankings, it provides a platform for significant discourse and innovation in pathology. Operating from the United Kingdom, AJSP-Reviews and Reports is positioned to bridge gaps in knowledge and inspire future research developments. Readers can access valuable findings without open access barriers, allowing for efficient information sharing within the medical field.

Diagnostic Pathology

Empowering Researchers with High-Quality Pathology Insights
Publisher: BMCISSN: Frequency: 1 issue/year

Diagnostic Pathology is a prominent open-access journal published by BMC, dedicated to advancing the field of pathology by providing a platform for high-quality research findings since its inception in 2006. Based in the United Kingdom, the journal covers a broad spectrum of topics within the realms of histology, pathology, and forensic medicine, facilitating discussions that are crucial for both clinical and laboratory settings. With an impressive impact factor that places it in the Q2 category across multiple categories including Histology and Miscellaneous Medicine, it ranks favorably in Scopus with notable positions in the 71st and 55th percentiles for Pathology and Histology respectively. As a valuable resource for researchers, professionals, and students alike, Diagnostic Pathology promotes the dissemination of cutting-edge studies and findings, thereby contributing significantly to the evolving landscape of medical science. The journal’s commitment to open access enhances its accessibility, ensuring that valuable research is freely available to a global audience.

Oral & Maxillofacial Pathology Journal

Advancing Knowledge in Oral Health
Publisher: KAIRALI SOC ORAL & MAXILLOFACIAL PATHOLOGISTSISSN: 0976-1225Frequency: 2 issues/year

Oral & Maxillofacial Pathology Journal is a prominent peer-reviewed publication dedicated to advancing the field of oral and maxillofacial pathology. Published by the KAIRALI SOCIETY OF ORAL & MAXILLOFACIAL PATHOLOGISTS, this journal aims to provide a platform for sharing innovative research, clinical practices, and new techniques related to the diagnosis and management of oral diseases. With a commitment to open access, it ensures that valuable knowledge reaches a global audience of researchers, dental professionals, and students alike. Although specific impact metrics such as the HIndex and Scopus ranking are not listed, the journal is regarded as an essential resource for those involved in the oral health community. It plays a crucial role in fostering collaboration and disseminating cutting-edge advancements that can enhance patient care and clinical outcomes in oral pathology. For professionals looking to stay ahead in this dynamic field, Oral & Maxillofacial Pathology Journal serves as an indispensable tool for both foundational learning and advanced research.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Advancing Knowledge in Experimental Pathology
Publisher: WILEYISSN: 0959-9673Frequency: 6 issues/year

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.

HISTOPATHOLOGY

Exploring Innovations in Histology and Pathology
Publisher: WILEYISSN: 0309-0167Frequency: 12 issues/year

HISTOPATHOLOGY is a premier scholarly journal published by WILEY, targeting the fields of histology, pathology, and forensic medicine. With an ISSN of 0309-0167 and an E-ISSN of 1365-2559, this esteemed journal has maintained a strong academic presence since its inception in 1977. Boasting an impressive Q1 ranking in crucial categories such as Histology and Pathology, it ranks 13th out of 208 in Pathology and Forensic Medicine, and 5th out of 62 in Histology, reflecting its high impact and relevance within the scientific community. HISTOPATHOLOGY serves as a critical platform for disseminating significant research findings, reviews, and advancements in the diagnostic and therapeutic aspects of pathology. Although it does not operate under an open access model, its rigorous peer-review process ensures that published articles uphold the highest standards of scientific integrity. Scholars and practitioners alike benefit from the insights shared in this journal, as it aims to bridge the gap between laboratory science and clinical practice, fostering innovation and enhancing our understanding of disease mechanisms.